BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21954835)

  • 1. Increased apoptosis in cryopreserved autologous hematopoietic progenitor cells collected by apheresis and delayed neutrophil recovery after transplantation: a nested case-control study.
    Wu L; Al-Hejazi A; Filion L; Ben R; Halpenny M; Yang L; Giulivi A; Allan DS
    Cytotherapy; 2012 Feb; 14(2):205-14. PubMed ID: 21954835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predicting haematopoietic recovery in patients undergoing autologous transplantation: 11-year experience from a single centre.
    Bai L; Xia W; Wong K; Reid C; Ward C; Greenwood M
    Ann Hematol; 2014 Oct; 93(10):1655-64. PubMed ID: 24870941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry quantification of CD34+ cells and other leukocyte subpopulations in frozen-thawed blood cell suspensions: investigation of a new teflon container for cryopreservation of hematopoietic progenitor cells.
    Arseniev L; Goudeva L; Kadar JG; Südmeier I; Battmer K; Matheja S; Mitschulat H; Stangel W; Link H
    Infusionsther Transfusionsmed; 1995 Jun; 22(3):152-8. PubMed ID: 7543782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
    Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
    Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manufacture of Autologous CD34
    Keever-Taylor CA; Heimfeld S; Steinmiller KC; Nash RA; Sullivan KM; Czarniecki CW; Granderson TC; Goldstein JS; Griffith LM
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1463-1472. PubMed ID: 28602891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
    Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
    Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
    Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
    Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of incubation temperature and time after thawing on viability assessment of peripheral hematopoietic progenitor cells cryopreserved for transplantation.
    Yang H; Acker JP; Cabuhat M; McGann LE
    Bone Marrow Transplant; 2003 Nov; 32(10):1021-6. PubMed ID: 14595390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sepax-2 cell processing device: a study assessing reproducibility of concentrating thawed hematopoietic progenitor cells.
    Mfarrej B; Vicari O; Ouffai S; Malenfant C; Granata A; Thevenet S; Chabannon C; Lemarié C; Calmels B
    J Transl Med; 2022 Nov; 20(1):503. PubMed ID: 36329460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early apoptosis largely accounts for functional impairment of CD34+ cells in frozen-thawed stem cell grafts.
    de Boer F; Dräger AM; Pinedo HM; Kessler FL; Monnee-van Muijen M; Weijers G; Westra G; van der Wall E; Netelenbos T; Oberink JW; Huijgens PC; Schuurhuis GJ
    J Hematother Stem Cell Res; 2002 Dec; 11(6):951-63. PubMed ID: 12590710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cryopreserved murine and human hematopoietic stem and progenitor cells designated for transplantation.
    Balint B; Ivanović Z; Petakov M; Taseski J; Vojvodić D; Jovcić G; Bugarski D; Marjanović S; Malesević M; Stojanović N
    Vojnosanit Pregl; 1999; 56(6):577-85. PubMed ID: 10707606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mononuclear cell dose of 3 x 10(8)/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation.
    Smith RJ; Sweetenham JW
    Exp Hematol; 1995 Dec; 23(14):1581-8. PubMed ID: 8542950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryopreservation and thawing of hematopoietic stem cell CD34-induced apoptosis through caspase pathway activation: Key role of granulocytes.
    Desoutter J; Ossart C; Lacassagne MN; Regnier A; Marolleau JP; Harrivel V
    Cytotherapy; 2019 Jun; 21(6):612-618. PubMed ID: 31056424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation.
    de Boer F; Dräger AM; Pinedo HM; Kessler FL; van der Wall E; Jonkhoff AR; van der Lelie J; Huijgens PC; Ossenkoppele GJ; Schuurhuis GJ
    Bone Marrow Transplant; 2002 Feb; 29(3):249-55. PubMed ID: 11859398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
    Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
    Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral Stem Cell Apheresis is Feasible Post
    Kraal KCJM; Timmerman I; Kansen HM; van den Bos C; Zsiros J; van den Berg H; Somers S; Braakman E; Peek AML; van Noesel MM; van der Schoot CE; Fiocco M; Caron HN; Voermans C; Tytgat GAM
    Clin Cancer Res; 2019 Feb; 25(3):1012-1021. PubMed ID: 30314967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryopreserved mobilized autologous blood progenitors stored for more than 2 years successfully support blood count recovery after high-dose chemotherapy.
    Cameron G; Tantiworawit A; Halpenny M; Letcher B; Berrigan S; Hindmarsh K; Giftakis A; Fortier J; O'Hoski P; Hogge D
    Cytotherapy; 2011 Aug; 13(7):856-63. PubMed ID: 21385094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of CD34+ cell numbers and colony growth before and after cryopreservation of peripheral blood progenitor and stem cell harvests: influence of prior chemotherapy.
    Humpe A; Riggert J; Vehmeyer K; Troff C; Hiddemann W; Köhler M; Wörmann B
    Transfusion; 1997 Oct; 37(10):1050-7. PubMed ID: 9354824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes.
    Keyzner A; Azzi J; Jakubowski R; Sinitsyn Y; Tindle S; Shpontak S; Kwon D; Isola L; Iancu-Rubin C
    Transplant Proc; 2023 Oct; 55(8):1799-1809. PubMed ID: 37210273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of cryopreservation on clinically prepared hematopoietic progenitor cell products.
    Winter JM; Jacobson P; Bullough B; Christensen AP; Boyer M; Reems JA
    Cytotherapy; 2014 Jul; 16(7):965-75. PubMed ID: 24910385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.